Advertisement

Intensive Care Medicine

, Volume 38, Issue 7, pp 1239–1240 | Cite as

Surviving life-threatening MDMA (3,4-methylenedioxymethamphetamine, ecstasy) toxicity caused by ritonavir (RTV)

  • Esther PapaseitEmail author
  • Antonia Vázquez
  • Clara Pérez-Mañá
  • Mitona Pujadas
  • Rafael de la Torre
  • Magí Farré
  • Joan Nolla
Correspondence

Keywords

Ritonavir Ecstasy Disseminate Intravascular Coagulation MDMA Atazanavir 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Acknowledgments

This work was supported by grants from DIUE de la Generalitat de Catalunya (2009 SGR 718), ISCIII-FEDER-FIS-RTA RD06/0001/1009 and ISCIII-FIS-CAIBER CAI08/01/0024.

References

  1. 1.
    Yubero-Lahoz S, Pardo R, Farré M, O’Mahony B, Torrens M, Mustata C, Pérez-Mañá C, Carbó ML, de la Torre R (2011) Sex differences in 3,4-methylenedioxymethamphetamine (MDMA; ecstasy)-induced cytochrome P450 2D6 inhibition in humans. Clin Pharmacokinet 50:319–329PubMedCrossRefGoogle Scholar
  2. 2.
    Henry JA, Hill IR (1998) Fatal interaction between ritonavir and MDMA. Lancet 352:1751–1752PubMedCrossRefGoogle Scholar
  3. 3.
    Harrington RD, Woodward JA, Hooton TM, Horn JR (1999) Life-threatening interactions between HIV-1 protease inhibitors and the illicit drugs MDMA and gamma-hydroxybutyrate. Arch Intern Med 159:2221–2224PubMedCrossRefGoogle Scholar
  4. 4.
    de la Torre R, Farré M, Ortuño J, Mas M, Brenneisen R, Roset PN, Segura J, Camí J (2000) Non-linear pharmacokinetics of MDMA (‘ecstasy’) in humans. Br J Clin Pharmacol 49:104–109PubMedCrossRefGoogle Scholar
  5. 5.
    O’Mathúna B, Farré M, Rostami-Hodjegan A, Yang J, Cuyàs E, Torrens M, Pardo R, Abanades S, Maluf S, Tucker GT, de la Torre R (2008) The consequences of 3,4-methylenedioxymethamphetamine induced CYP2D6 inhibition in humans. J Clin Psychopharmacol 28:523–529PubMedCrossRefGoogle Scholar

Copyright information

© Copyright jointly held by Springer and ESICM 2012

Authors and Affiliations

  • Esther Papaseit
    • 1
    • 4
    Email author
  • Antonia Vázquez
    • 2
  • Clara Pérez-Mañá
    • 1
    • 4
  • Mitona Pujadas
    • 1
  • Rafael de la Torre
    • 1
    • 3
  • Magí Farré
    • 1
    • 4
  • Joan Nolla
    • 2
    • 3
  1. 1.Human Pharmacology and Clinical Neurosciences Research Group, Neurosciences Research ProgramIMIM-Hospital del Mar Research InstituteBarcelonaSpain
  2. 2.Intensive Care UnitHospital del MarBarcelonaSpain
  3. 3.Department of Experimental and Health Sciences-CEXS-(UPF)BarcelonaSpain
  4. 4.Department of Pharmacology, Therapeutics and ToxicologyUniversitat Autònoma de Barcelona (UAB)BarcelonaSpain

Personalised recommendations